组织驻留CD8+T细胞在肿瘤中的研究进展

刘仕锦 林宇健 何嘉帅 张磊 潘运龙 潘京华

刘仕锦, 林宇健, 何嘉帅, 张磊, 潘运龙, 潘京华. 组织驻留CD8+T细胞在肿瘤中的研究进展[J]. 中国肿瘤临床, 2022, 49(12): 622-626. doi: 10.12354/j.issn.1000-8179.2022.20211441
引用本文: 刘仕锦, 林宇健, 何嘉帅, 张磊, 潘运龙, 潘京华. 组织驻留CD8+T细胞在肿瘤中的研究进展[J]. 中国肿瘤临床, 2022, 49(12): 622-626. doi: 10.12354/j.issn.1000-8179.2022.20211441
Shijin Liu, Yujian Lin, Jiashuai He, Lei Zhang, Yunlong Pan, Jinghua Pan. Research progress on tissue-resident CD8+ T cells in tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 49(12): 622-626. doi: 10.12354/j.issn.1000-8179.2022.20211441
Citation: Shijin Liu, Yujian Lin, Jiashuai He, Lei Zhang, Yunlong Pan, Jinghua Pan. Research progress on tissue-resident CD8+ T cells in tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 49(12): 622-626. doi: 10.12354/j.issn.1000-8179.2022.20211441

组织驻留CD8+T细胞在肿瘤中的研究进展

doi: 10.12354/j.issn.1000-8179.2022.20211441
基金项目: 本文课题受广东省基础与应用基础基金项目(编号:2019A1515110543)资助
详细信息
    作者简介:

    刘仕锦:专业方向为胃肠外科的临床与基础研究

    通讯作者:

    潘京华 huajanve@foxmail.com

Research progress on tissue-resident CD8+ T cells in tumors

Funds: This work was supported by the Basic and Applied Basic Research Fund of Guangdong Province (No. 2019A1515110543)
More Information
  • 摘要: 组织驻留记忆 T 细胞( tissue-resident memory T cells,TRMs)作为一种特殊的记忆T细胞,在免疫应答中发挥着极其重要的作用。其特征是可表达归巢受体,从而具备驻留特性,因此能够驻留在外周组织器官中,当病原体侵袭时可以迅速反应。目前,TRMs(尤其是CD8+TRMs)与肿瘤的关系及其在抗肿瘤中的应用被愈加重视,一方面是CD8+TRMs可以通过分泌颗粒酶B、穿孔素和INF-γ等因子直接杀伤肿瘤细胞,另一方面一些抗肿瘤措施(如放化疗、免疫治疗等)可以使CD8+TRMs在肿瘤组织中富集,从而进一步提高治疗的效果。本文就CD8+TRMs的亚群分类、在肿瘤中如何调控形成以及其在肿瘤治疗中的作用等方面的研究进展进行综述。

     

  • 图  1  TRMs的形成及其调控的相关机制

    图  2  TRMs抗肿瘤的相关机制示意

  • [1] Sallusto F, Lenig D, Förster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions[J]. Nature, 1999, 401(6754):708-712. doi: 10.1038/44385
    [2] Thom JT, Weber TC, Walton SM, et al. The salivary gland acts as a sink for tissue-resident memory CD8(+) T cells, facilitating protection from local cytomegalovirus infection[J]. Cell Rep, 2015, 13(6):1125-1136. doi: 10.1016/j.celrep.2015.09.082
    [3] Wu QL, Kang SP, Wu CY. The progress of tissue resident memory T-cells against tumors[J]. Sci Sin Vitae, 2020, 50(10):1032-1041. doi: 10.1360/SSV-2020-0024
    [4] Snyder ME, Farber DL. Human lung tissue resident memory T cells in health and disease[J]. CurrOpin Immunol, 2019, 59:101-108. doi: 10.1016/j.coi.2019.05.011
    [5] Nizard M, Roussel H, Diniz MO, et al. Induction of resident memory T cells enhances the efficacy of cancer vaccine[J]. Nat Commun, 2017, 8(1):15221-15232. doi: 10.1038/ncomms15221
    [6] Enamorado M, Iborra S, Priego E, et al. Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells[J]. Nat Commun, 2017, 8(1):16073-16084. doi: 10.1038/ncomms16073
    [7] Masopust D, Soerens AG. Tissue-resident T cells and other resident leukocytes[J]. Annu Rev Immunol, 2019, 37(1):521-546. doi: 10.1146/annurev-immunol-042617-053214
    [8] Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in immune defence[J]. Nat Rev Immunol, 2016, 16(2):79-89. doi: 10.1038/nri.2015.3
    [9] 刘洋,闫冬梅.组织定居T细胞的免疫学特征研究进展[J].化工时刊,2021,35(3):28-30.
    [10] Iijima N, Iwasaki A. Tissue instruction for migration and retention of TRM cells[J]. Trends Immunol, 2015, 36(9):556-564. doi: 10.1016/j.it.2015.07.002
    [11] Dumauthioz N, Labiano S, Romero P. Tumor resident memory T cells: new players in immune surveillance and therapy[J]. Front Immunol, 2018, 9:2076-2082. doi: 10.3389/fimmu.2018.02076
    [12] Byrne A, Savas P, Sant S, et al. Tissue-resident memory T cells in breast cancer control and immunotherapy responses[J]. Nat Rev Clin Oncol, 2020, 17(6):341-348. doi: 10.1038/s41571-020-0333-y
    [13] Cheuk S, Schlums H, GallaisSérézal I, et al. CD49a expression defines tissue-resident CD8+T cells poised for cytotoxic function in human skin[J]. Immunity, 2017, 46(2):287-300. doi: 10.1016/j.immuni.2017.01.009
    [14] Pan Y, Tian T, Park CO, et al. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism[J]. Nature, 2017, 543(7644):252-256. doi: 10.1038/nature21379
    [15] Wijeyesinghe S, Beura LK, Pierson MJ, et al. Expansible residence decentralizes immune homeostasis[J]. Nature, 2021, 592(7854):457-462. doi: 10.1038/s41586-021-03351-3
    [16] Reading JL, Gálvez-Cancino F, Swanton C, et al. The function and dysfunction of memory CD8+T cells in tumor immunity[J]. Immunol Rev, 2018, 283(1):194-212. doi: 10.1111/imr.12657
    [17] Lin R, Zhang H, Yuan Y, et al. Fatty acid oxidation controls CD8+tissue-resident memory T-cell survival in gastric adenocarcinoma[J]. Cancer Immunol Res, 2020, 8(4):479-492.
    [18] Garrido-Martin EM, Mellows TWP, Clarke J, et al. M1hot tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer[J]. J Immunother Cancer, 2020, 8(2):e000778. doi: 10.1136/jitc-2020-000778
    [19] Edwards J, Wilmott JS, Madore J, et al. CD103+tumor-resident CD8+ T cells are associated with improved survival in immunotherapy-naïve melanoma patients and expand significantly during anti-PD-1 treatment[J]. Clin Cancer Res, 2018, 24(13):3036-3045. doi: 10.1158/1078-0432.CCR-17-2257
    [20] Okła K, Farber DL, Zou W. Tissue-resident memory T cells in tumor immunity and immunotherapy[J]. J Exp Med, 2021, 218(4):e20201605. doi: 10.1084/jem.20201605
    [21] Mackay LK, Wynne-Jones E, Freestone D, et al. T-box transcription factors combine with the cytokines TGF-β and IL-15 to control tissue-resident memory T cell fate[J]. Immunity, 2015, 43(6):1101-1111. doi: 10.1016/j.immuni.2015.11.008
    [22] Mackay LK, Kallies A. Transcriptional regulation of tissue-resident lymphocytes[J]. Trends Immunol, 2017, 38(2):94-103. doi: 10.1016/j.it.2016.11.004
    [23] Li C, Zhu B, Son YM, et al. The transcription factor bhlhe40 programs mitochondrial regulation of resident CD8+ T cell fitness and functionality[J]. Immunity, 2019, 51(3):491-507. doi: 10.1016/j.immuni.2019.08.013
    [24] Hartana CA, Ahlén Bergman E, Broomé A, et al. Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer[J]. Clin Exp Immunol, 2018, 194(1):39-53. doi: 10.1111/cei.13183
    [25] Park SL, Gebhardt T, Mackay LK. Tissue-resident memory T cells in cancer immunosurveillance[J]. Trends Immunol, 2019, 40(8):735-747. doi: 10.1016/j.it.2019.06.002
    [26] Savas P, Virassamy B, Ye C, et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis[J]. Nat Med, 2018, 24(7):986-993. doi: 10.1038/s41591-018-0078-7
    [27] Djenidi F, Adam J, Goubar A, et al. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients[J]. J Immunol, 2015, 194(7):3475-3486. doi: 10.4049/jimmunol.1402711
    [28] Brewitz A, Eickhoff S, Dähling S, et al. CD8+ T cells orchestrate pDC-XCR1+dendritic cell spatial and functional cooperativity to optimize priming[J]. Immunity, 2017, 46(2):205-219. doi: 10.1016/j.immuni.2017.01.003
    [29] Prasad S, Lokensgard JR. Brain-resident T cells following viral infection[J]. Viral Immunol, 2019, 32(1):48-54. doi: 10.1089/vim.2018.0084
    [30] Duhen T, Duhen R, Montler R, et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors[J]. Nat Commun, 2018, 9(1):2724. doi: 10.1038/s41467-018-05072-0
    [31] Marceaux C, Weeden CE, Gordon CL, et al. Holding our breath: the promise of tissue-resident memory T cells in lung cancer[J]. Transl Lung Cancer Res, 2021, 10(6):2819-2829. doi: 10.21037/tlcr-20-819
    [32] Menares E, Gálvez-Cancino F, Cáceres-Morgado P, et al. Tissue-resident memory CD8+T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells[J]. Nat Commun, 2019, 10(1):4401-4413. doi: 10.1038/s41467-019-12319-x
    [33] Han J, Khatwani N, Searles TG, et al. Memory CD8+T cell responses to cancer[J]. Semin Immunol, 2020, 49:101435-101445. doi: 10.1016/j.smim.2020.101435
    [34] Lauret Marie Joseph E, Kirilovsky A, Lecoester B, et al. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy[J]. J Immunother Cancer, 2021, 9(7):e002256. doi: 10.1136/jitc-2020-002256
    [35] Martinez M, Moon EK. Car T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment[J]. Front Immunol, 2019, 10:128-149. doi: 10.3389/fimmu.2019.00128
  • 加载中
图(2)
计量
  • 文章访问数:  517
  • HTML全文浏览量:  195
  • PDF下载量:  71
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-25
  • 录用日期:  2022-03-25
  • 网络出版日期:  2022-06-27

目录

    /

    返回文章
    返回